ArticleScience progress
The association between lactate trajectories and prognosis in ICU patients with pneumonia: A retrospective group-based trajectory model analysis.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo identify pneumonia-specific lactate trajectory phenotypes and evaluate their association with 28-day mortality in ICU patients with pneumonia.MethodsA retrospective cohort study was performed using the MIMIC-IV database. Adult ICU patients with pneumonia were identified via ICD-9/10 codes. Exclusions were non-index ICU admissions, age <18 or >100 years, ICU stay <3 days, and incomplete lactate data in the first 72 hours. Demographics, vital signs, laboratory results, comorbidities, severity scores, and treatments were extracted. Group-based trajectory modeling (GBTM) was applied to lactate values over 72 hours. Model selection considered BIC, AIC, average posterior probability (AvePP), odds of correct classification (OCC), class size, and clinical interpretability. Outcomes included 28-day all-cause mortality (primary) and secondary endpoints. Kaplan-Meier analysis and Cox regression were used to examine associations, with subgroup analyses across demographic and clinical strata.ResultsA total of 2,091 patients were included. Four distinct lactate trajectories were identified: low-stable (n=1161), moderate with gradual decline (n=721), initial rise then decline (n=89), and very high with rapid decline (n=120). Unfavorable trajectory classes were associated with greater illness severity, metabolic derangements, resource use, and higher mortality. As a continuous variable, lactate showed a borderline association with 28-day mortality in unadjusted analysis (HR 1.03, 95% CI 1.00-1.05, p=0.082), but lost significance after adjustment. In contrast, trajectory-based groups remained independently associated with outcomes: fully adjusted HRs were 1.30 (95% CI 1.08-1.56, p=0.004) for class 2, 1.49 (95% CI 1.03-2.15, p=0.034) for class 3, and 1.71 (95% CI 1.20-2.45, p=0.003) for class 4. Subgroup analyses showed consistent associations, with a stronger effect in patients <65 years (p for interaction=0.033).ConclusionsIn ICU patients with pneumonia, 72-hour lactate trajectory phenotypes were independently associated with 28-day mortality and may help characterize prognostic heterogeneity, including delayed lactate elevation patterns not captured by admission lactate alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.